Mounjaro (Tirzepatide) 7.5 mg Injection is a once-weekly injectable medication used to treat type 2 diabetes mellitus in adults. Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. These combined effects help improve blood sugar control and may contribute to weight loss. The 7.5 mg dose is typically used as part of a stepwise titration process.

• Dual hormone action improves glycemic control more effectively than GLP-1 alone

• Supports both fasting and postprandial glucose reduction

• Promotes weight loss in people with type 2 diabetes

• Once-weekly dosing for convenience

• Can be used with or without other diabetes medications

• Inject subcutaneously once a week on the same day each week

• Administer in the abdomen, upper arm, or thigh

• Use a new pen for each weekly dose

• Rotate injection sites with each administration

• 7.5 mg is typically used after initiating therapy at a lower dose (e.g., 2.5 mg, then 5 mg)

• Not recommended as a starting dose

• May be increased to higher doses based on therapeutic response and tolerability

• Must be used alongside diet and exercise

• Not suitable for patients with type 1 diabetes or diabetic ketoacidosis

• Contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or MEN 2

• Use caution in patients with gastrointestinal or renal conditions

• Not recommended during pregnancy or breastfeeding unless directed by a healthcare provider

• Common side effects:

• Nausea

• Vomiting

• Serious (rare) side effects:

• Pancreatitis

• Hypoglycemia (especially with other antidiabetic drugs)

• Kidney problems from dehydration

• Injection site reactions or allergic responses

•  

• Diarrhea

• Constipation

• Loss of appetite

• Store in a refrigerator at 2°C to 8°C

• Do not freeze

• May be kept at room temperature (up to 30°C) for up to 21 days

• Keep in the original carton to protect from light

• Store out of reach of children

Q1. When is the 7.5 mg dose used in treatment?
It is used after successful initiation and tolerance of lower doses to gradually reach therapeutic goals.

Q2. Can I take Mounjaro with metformin or insulin?
Yes, Mounjaro can be used in combination with other antidiabetic medications, as prescribed.

Q3. What should I do if I miss my dose?
If you miss a dose, take it within 4 days. If more than 4 days have passed, skip it and take the next dose on your scheduled day.

Q4. How soon will I see results?
Many patients observe improved blood sugar levels within a few weeks, with weight reduction becoming noticeable over time.